Biomarin Pharmaceutical (BMRN) Net Equity Issued and Repurchased (2012 - 2015)
Biomarin Pharmaceutical's (BMRN) quarterly Net Equity Issued and Repurchased came in at $888.3 million in Q1 2015, up 655.96% YoY from $117.5 million in Q1 2014, and up 2467480.56% on a QoQ basis from -$36000.0 in Q2 2014.
Biomarin Pharmaceutical (BMRN) Net Equity Issued and Repurchased (2012 - 2015) Analysis & Trends
Biomarin Pharmaceutical (BMRN) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $888.3 million in Q1 2015.
- Quarterly Net Equity Issued and Repurchased rose 655.96% year-over-year to $888.3 million in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $888.3 million (up 656.2% YoY) and the FY2016 annual result came in at $712.9 million, down 19.74% from the prior year.
- Net Equity Issued and Repurchased grew to $888.3 million in Q1 2015, from -$36000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $888.3 million in Q1 2015 to a low of -$36000.0 in Q2 2014.
- A 3-year average of $310.3 million and a median of $176.5 million in 2012 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 655.96% in 2015, down 655.96% in 2015.
- Tracing BMRN's Net Equity Issued and Repurchased over 3 years: stood at $235.5 million in 2012, then plunged by 100.02% to -$36000.0 in 2014, then jumped by 2467480.56% to $888.3 million in 2015.
- The last three Net Equity Issued and Repurchased figures came in at $888.3 million (Q1 2015), -$36000.0 (Q2 2014), and $117.5 million (Q1 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Biomarin Pharmaceutical | 13.04 Bn | 12.16 Bn | 786.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 888.26 Mn |
| Mar 31, 2015 | 888.26 Mn |
| Jun 30, 2014 | -36,000.00 |
| Jun 30, 2014 | -36,000.00 |
| Mar 31, 2014 | 117.50 Mn |
| Mar 31, 2014 | 117.50 Mn |
| Jun 30, 2012 | 235.50 Mn |
| Jun 30, 2012 | 235.50 Mn |